The Canadian federal government’s decision to cover diabetes medication and devices under its new pharmacare plan is a significant step forward in improving the quality of life for the millions of Canadians with diabetes, especially those who str…
Category: Diabetes
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
Can weight loss medication interfere with ADHD meds?
Why bother going to work? If I didn’t work, I wouldn’t get paid, so there was that. But it seemed like a pointless exercise. I would stare at my monitor until it was time to go home. On some level I knew I should be, well, working, but I co…
Health care disparities: Navigating complex care [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! We delve into the challenges faced by individuals who navigate complex health care systems with multiple chronic conditions. Our guest, Gary Marc Rothenberg, a podiatrist,…
KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs
KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of adults report having t…
Poll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease
About one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce the risk of heart disease and stroke, a new KFF Health Trackin…
Growing up with diabetes
An excerpt from Sugar Free. “What do you want to do?” Ginny said. “Chinese jump rope.” “Tilly, you always want to play Chinese jump rope,” Renée said. “So?” Tilly said. Renée didn’t have an answer t…
Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees
Most Medicare enrollees likely were not paying a monthly average of $400 — as President Joe Biden stated — before the insulin cap took effect. However, because costs and other factors result in widely varying prices, some Medicare enrollees might have paid that much in a given month.
As AI Eye Exams Prove Their Worth, Lessons for Future Tech Emerge
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
An Arm and a Leg: Wait, Is Insulin Cheaper Now?
Did the price of insulin go down? It’s not quite that simple. On this episode of “An Arm and a Leg,” producer Emily Pisacreta explores recent changes to the cost of the diabetes medication.
